BeStock  
Markets › Compare › BIO vs GKOS

BIO vs GKOS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BIO · Bio-Rad Laboratories$358.90 ▼ 2.34%
GKOS · Glaukos$237.31 ▼ 0.33%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

64114164213263Nov 24, '25May 26, '26Nov 20, '26
  • BIO +11.3%
  • GKOS +142.0%

Head to head

MetricBIOGKOS
Price$358.90$237.31
Change today▼ 2.34%▼ 0.33%
Market cap$9.65B$14.05B
Return, 3 months-6.0%+27.8%
Return, year to date+18.5%+110.2%
Return, 1 year+13.3%+138.2%
P/E (TTM)9.5–
P/B1.319.6
P/E percentile vs own 5y81st1st
Dividend yield––
Revenue growth (YoY, latest qtr)+0.5%+58.0%
Net profit growth (YoY)+234.1%+112.4%
Gross margin51.3%64.8%
Operating margin6.2%-25.3%
Net margin39.5%-24.6%
Return on equity14.3%-22.8%
Analyst target vs. price+22.6%+0.2%
Analyst buy share100%91%
RSI (14)4361
30-day volatility30.3%97.4%
Max drawdown, 1 year-27.2%-28.4%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GKOS is the largest of the group by market value.
  • GKOS has returned the most over the past year.
  • GKOS is growing revenue fastest.
  • BIO keeps the most profit per dollar of sales.
  • BIO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top